Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Mariell Rivedal"'
Autor:
Mariell Rivedal, Yngvar Lunde Haaskjold, Øystein Eikrem, Rune Bjørneklett, Hans Peter Marti, Thomas Knoop
Publikováno v:
BMC Nephrology, Vol 25, Iss 1, Pp 1-12 (2024)
Abstract Background Despite several clinical trials, the use of corticosteroid therapy for treating immunoglobulin A nephropathy (IgAN) remains controversial. We aimed to describe the use of corticosteroid therapy combined with supportive therapy in
Externí odkaz:
https://doaj.org/article/824b5472344a465098883508634bfa13
Autor:
Hassan Osman Alhassan Elsaid, Mariell Rivedal, Eleni Skandalou, Einar Svarstad, Camilla Tøndel, Even Birkeland, Øystein Eikrem, Janka Babickova, Hans-Peter Marti, Jessica Furriol
Publikováno v:
Journal of Translational Medicine, Vol 21, Iss 1, Pp 1-15 (2023)
Abstract Background Fabry disease (FD) is a rare lysosomal storage disorder caused by mutations in the GLA gene, resulting in reduced or lack of α-galactosidase A activity. This results in the accumulation of globotriaosylceramide (Gb3) and other gl
Externí odkaz:
https://doaj.org/article/4ff8c0c1e6f84277b262dad7adbc6a2e
Publikováno v:
Kidney Medicine, Vol 5, Iss 10, Pp 100709- (2023)
Antiglomerular basement membrane (anti-GBM) disease is a rare, small-vessel vasculitis that affects the capillary beds of the kidneys and lungs. Although exceedingly rare, several case reports have described anti-GBM disease with a concurrent cancer
Externí odkaz:
https://doaj.org/article/ce8ce670c78240f99425be0e8e97e2ed
Autor:
Philipp Strauss, Mariell Rivedal, Andreas Scherer, Øystein Eikrem, Sigrid Nakken, Christian Beisland, Leif Bostad, Arnar Flatberg, Eleni Skandalou, Vidar Beisvåg, Jessica Furriol, Hans-Peter Marti
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-15 (2022)
Abstract Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer. Identification of ccRCC likely to progress, despite an apparent low risk at the time of surgery, represents a key clinical issue. From a cohort of adult ccRCC patients
Externí odkaz:
https://doaj.org/article/4eeaf6c69c79445dafaf83fb89e0844a
Autor:
Hassan Osman Alhassan, Elsaid, Håkon, Tjeldnes, Mariell, Rivedal, Camille, Serre, Øystein, Eikrem, Einar, Svarstad, Camilla, Tøndel, Hans-Peter, Marti, Jessica, Furriol, Janka, Babickova
Publikováno v:
International journal of molecular sciences. 24(1)
Fabry disease (FD) is an X-linked inborn metabolic disorder due to partial or complete lysosomal α-galactosidase A deficiency. FD is characterized by progressive renal insufficiency and cardio- and cerebrovascular involvement. Restricted access on G
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::a8bddeb6f4d91e82938891d5145f77f7
https://pubmed.ncbi.nlm.nih.gov/36613802
https://pubmed.ncbi.nlm.nih.gov/36613802
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS Despite several clinical trials, treatment with corticosteroids in patients with Immunoglobulin A nephropathy (IgAN) remains controversial [1, 2]. The recently updated KDIGO guidelines suggests that treatment with corticosteroids
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::947134dcc8a7a8b7f94f90aaf7b4da00
https://doi.org/10.1093/ndt/gfac067.067
https://doi.org/10.1093/ndt/gfac067.067
Autor:
Mariell Rivedal, Håvard Mikkelsen, Thomas Knoop, Rune Bjørneklett, Yngvar Lunde Haaskjold, Jessica Furriol, Hans-Peter Marti, Andreas Scherer, Øystein Eikrem, Philipp Strauss
Publikováno v:
Nephrology Dialysis Transplantation. 37
BACKGROUND AND AIMS IgA nephropathy (IgAN) is the most common primary glomerulonephritis worldwide. We have previously shown that patients with assumed benign IgAN can develop progressive kidney failure, including end-stage kidney disease, after a su
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53245889470949e93249f5f41cfb0234
https://doi.org/10.1093/ndt/gfac070.061
https://doi.org/10.1093/ndt/gfac070.061